Literature DB >> 16319128

Distinct expression profile in fumarate-hydratase-deficient uterine fibroids.

Sakari Vanharanta1, Patrick J Pollard, Heli J Lehtonen, Päivi Laiho, Jari Sjöberg, Arto Leminen, Kristiina Aittomäki, Johanna Arola, Mogens Kruhoffer, Torben F Orntoft, Ian P Tomlinson, Maija Kiuru, Diego Arango, Lauri A Aaltonen.   

Abstract

Defects in mitochondrial enzymes predispose to severe developmental defects as well as tumorigenesis. Heterozygous germline mutations in the nuclear gene encoding fumarate hydratase (FH), an enzyme catalyzing the hydration of fumarate in the Krebs tricarboxylic acid cycle, cause hereditary leiomyomatosis and renal cell cancer; yet the connection between disruption of mitochondrial metabolic pathways and neoplasia remains to be discovered. We have used an expression microarray approach for studying differences in global gene expression pattern caused by mutations in FH. Seven uterine fibroids carrying FH mutations were compared with 15 fibroids with wild-type FH. The two groups showed markedly different expression profiles, and multiple differentially expressed genes were detected. The most significant increase in FH mutants was seen in the expression of carbohydrate metabolism- and glycolysis-related genes. Other significantly up-regulated gene categories in FH mutants were, for example, iron ion homeostasis and oxidoreduction. Genes with lower expression in FH-mutant fibroids belonged to groups such as extracellular matrix, cell adhesion, muscle development and cell contraction. We show that FH mutations alter significantly the expression profiles of fibroids, most strikingly increasing the expression of genes involved in glycolysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319128     DOI: 10.1093/hmg/ddi431

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

1.  Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.

Authors:  Quanling Feng; John R Crochet; Qunsheng Dai; Phyllis C Leppert; Thomas M Price
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

2.  Fumarase is involved in DNA double-strand break resection through a functional interaction with Sae2.

Authors:  Michael Leshets; Dharanidharan Ramamurthy; Michael Lisby; Norbert Lehming; Ophry Pines
Journal:  Curr Genet       Date:  2017-12-04       Impact factor: 3.886

Review 3.  Revisiting the TCA cycle: signaling to tumor formation.

Authors:  Nuno Raimundo; Bora E Baysal; Gerald S Shadel
Journal:  Trends Mol Med       Date:  2011-07-20       Impact factor: 11.951

Review 4.  Oncometabolites in renal cancer.

Authors:  Cissy Yong; Grant D Stewart; Christian Frezza
Journal:  Nat Rev Nephrol       Date:  2019-10-21       Impact factor: 28.314

Review 5.  Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.

Authors:  Aikseng Ooi
Journal:  Semin Cancer Biol       Date:  2019-11-02       Impact factor: 15.707

6.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.

Authors:  Christian Frezza; Liang Zheng; Ori Folger; Kartik N Rajagopalan; Elaine D MacKenzie; Livnat Jerby; Massimo Micaroni; Barbara Chaneton; Julie Adam; Ann Hedley; Gabriela Kalna; Ian P M Tomlinson; Patrick J Pollard; Dave G Watson; Ralph J Deberardinis; Tomer Shlomi; Eytan Ruppin; Eyal Gottlieb
Journal:  Nature       Date:  2011-08-17       Impact factor: 49.962

7.  Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.

Authors:  Elaine D MacKenzie; Mary A Selak; Daniel A Tennant; Lloyd J Payne; Stuart Crosby; Casper M Frederiksen; David G Watson; Eyal Gottlieb
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

8.  LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.

Authors:  Han Xie; Vladimir A Valera; Maria J Merino; Angela M Amato; Sabina Signoretti; William M Linehan; Vikas P Sukhatme; Pankaj Seth
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

9.  Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.

Authors:  Julian Sanz-Ortega; Cathy Vocke; Pamela Stratton; William Marston Linehan; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

10.  Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer.

Authors:  Brian Shuch; Christopher J Ricketts; Cathy D Vocke; Vladimir A Valera; Clara C Chen; Rabi Gautam; Gopal N Gupta; Gabriela S Gomez Macias; Maria J Merino; Gennady Bratslavsky; W Marston Linehan
Journal:  J Urol       Date:  2012-09-19       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.